SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) — The Shareholders Foundation, Inc. announces that a lawsuit is pending against certain investors in Abbott Laboratories stock AWAY.
Investors who bought Abbott Laboratories AWAY Those purchasing shares prior to February 2021 and who continue to hold any of their NYSE: ABT stock also have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779-1554.
On August 31, 2022, a lawsuit was filed against Abbott Laboratories alleging violations of securities laws. Plaintiff alleges that the defendants made numerous materially false and misleading statements and omissions regarding conditions at the Company’s Sturgis infant formula manufacturing facility that the United States Food and Drug Administration (“FDA”) has described as “extremely unsanitary”. and that the defendants have repeatedly touted the safety and salability of Abbott’s infant formula brands and their contribution to the company’s sales and earnings growth to investors.
Those who bought Abbott Laboratories AWAY Shares please contact the Shareholders Foundation, Inc.
Shareholder Foundation, Inc.
+1 (858) 779-1554
3111 Camino Del Rio North
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and settlement filing service that conducts research on shareholder matters and keeps investors informed of securities class actions, settlements, judgments and other stock/financial market legal news. The Shareholders Foundation, Inc. is not a law firm. All named cases, investigations and/or settlements were not filed/initiated/achieved and/or are not related to the Shareholders Foundation. The information is provided as a public service only. It is not intended to be legal advice and should not be relied upon.
Read full story here https://www.benzinga.com/pressreleases/22/10/g29132244/nyse-abt-investor-notice-lawsuit-against-abbott-laboratories-over-alleged-securities-laws-violatio